Catalog4 refs
Chonluten (EDG)
Healing & RecoveryResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Body Map
Overview
Chonluten is a Khavinson bioregulator tripeptide (EDG) derived from respiratory lung tissue. Developed at Russia's St. Petersburg Institute of Bioregulation and Gerontology, it targets the bronchopulmonary system with secondary activity in the GI tract. Research shows it regulates genes related to inflammation, antioxidant activity, and proliferation responses. Chonluten inhibits TNF production in monocytes and has been studied as a potential geroprotective agent that may support lung function in conditions like COPD.
Primary Uses
Normalizes respiratory system function
Regulates protein synthesis in lung tissue
Inhibits inflammatory TNF production
Restores lung alveolar tissues
Maintains bronchial mucous membranes
Supports antioxidant gene expression
May slow cell aging (geroprotective)
Modulates mucosal function
COPD support
Oxidative stress reduction
Protocol Reference
Dose
10-20 mg daily
Frequency
Once daily for 10-20 consecutive days
Half-life
Minutes (short peptide); effects persist via epigenetic changes
Route
Oral capsules · Sublingual · Injectable
Evidence
Moderate Research
Research Models
Human
Also in Healing & Recovery